Literature DB >> 30419069

C/VDdb: A multi-omics expression profiling database for a knowledge-driven approach in cardiovascular disease (CVD).

Marco Fernandes1, Alisha Patel1, Holger Husi1,2.   

Abstract

The cardiovascular disease (C/VD) database is an integrated and clustered information resource that covers multi-omic studies (microRNA, genomics, proteomics and metabolomics) of cardiovascular-related traits with special emphasis on coronary artery disease (CAD). This resource was built by mining existing literature and public databases and thereafter manual biocuration was performed. To enable integration of omic data from distinct platforms and species, a specific ontology was applied to tie together and harmonise multi-level omic studies based on gene and protein clusters (CluSO) and mapping of orthologous genes (OMAP) across species. CAD continues to be a leading cause of death in the population worldwide, and it is generally thought to be an age-related disease. However, CAD incidence rates are now known to be highly influenced by environmental factors and interactions, in addition to genetic determinants. With the complexity of CAD aetiology, there is a difficulty in research studies to elucidate general elements compared to other cardiovascular diseases. Data from 92 studies, covering 13945 molecular entries (4353 unique molecules) is described, including data descriptors for experimental setup, study design, discovery-validation sample size and associated fold-changes of the differentially expressed molecular features (p-value<0.05). A dedicated interactive web interface, equipped with a multi-parametric search engine, data export and indexing menus are provided for a user-accessible browsing experience. The main aim of this work was the development of a data repository linking clinical information and molecular differential expression in several CVD-related traits from multi-omics studies (genomics, transcriptomics, proteomics and metabolomics). As an example case of how to query and identify data sets within the database framework and concomitantly demonstrate the database utility, we queried CAD-associated studies and performed a systems-level integrative analysis. URL: www.padb.org/cvd.

Entities:  

Mesh:

Year:  2018        PMID: 30419069      PMCID: PMC6231654          DOI: 10.1371/journal.pone.0207371

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  92 in total

Review 1.  Proteomics by mass spectrometry: approaches, advances, and applications.

Authors:  John R Yates; Cristian I Ruse; Aleksey Nakorchevsky
Journal:  Annu Rev Biomed Eng       Date:  2009       Impact factor: 9.590

2.  Priority actions for the non-communicable disease crisis.

Authors:  Quratulain Humayun; Shirin Mirza
Journal:  Lancet       Date:  2011-08-13       Impact factor: 79.321

Review 3.  Multidimensional proteomics for cell biology.

Authors:  Mark Larance; Angus I Lamond
Journal:  Nat Rev Mol Cell Biol       Date:  2015-04-10       Impact factor: 94.444

Review 4.  PPARs and their effects on the cardiovascular system.

Authors:  Adebayo Oyekan
Journal:  Clin Exp Hypertens       Date:  2011-07-01       Impact factor: 1.749

5.  The UDP-glucuronosyltransferase 1A9 enzyme is a peroxisome proliferator-activated receptor alpha and gamma target gene.

Authors:  Olivier Barbier; Lyne Villeneuve; Virginie Bocher; Coralie Fontaine; Ines Pineda Torra; Christian Duhem; Vladimir Kosykh; Jean-Charles Fruchart; Chantal Guillemette; Bart Staels
Journal:  J Biol Chem       Date:  2003-02-11       Impact factor: 5.157

6.  The protein kinase C signaling pathway regulates a molecular switch between transactivation and transrepression activity of the peroxisome proliferator-activated receptor alpha.

Authors:  Christophe Blanquart; Roxane Mansouri; Réjane Paumelle; Jean-Charles Fruchart; Bart Staels; Corine Glineur
Journal:  Mol Endocrinol       Date:  2004-05-06

Review 7.  Peroxisome proliferator-activated receptor alpha target genes.

Authors:  S Mandard; M Müller; S Kersten
Journal:  Cell Mol Life Sci       Date:  2004-02       Impact factor: 9.261

8.  DisGeNET: a discovery platform for the dynamical exploration of human diseases and their genes.

Authors:  Janet Piñero; Núria Queralt-Rosinach; Àlex Bravo; Jordi Deu-Pons; Anna Bauer-Mehren; Martin Baron; Ferran Sanz; Laura I Furlong
Journal:  Database (Oxford)       Date:  2015-04-15       Impact factor: 3.451

9.  The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible.

Authors:  Damian Szklarczyk; John H Morris; Helen Cook; Michael Kuhn; Stefan Wyder; Milan Simonovic; Alberto Santos; Nadezhda T Doncheva; Alexander Roth; Peer Bork; Lars J Jensen; Christian von Mering
Journal:  Nucleic Acids Res       Date:  2016-10-18       Impact factor: 16.971

10.  MicroRNAs as early toxicity signatures of doxorubicin in human-induced pluripotent stem cell-derived cardiomyocytes.

Authors:  Umesh Chaudhari; Harshal Nemade; John Antonydas Gaspar; Jürgen Hescheler; Jan G Hengstler; Agapios Sachinidis
Journal:  Arch Toxicol       Date:  2016-02-03       Impact factor: 5.153

View more
  4 in total

1.  Unsupervised classification of multi-omics data during cardiac remodeling using deep learning.

Authors:  Neo Christopher Chung; Bilal Mirza; Howard Choi; Jie Wang; Ding Wang; Peipei Ping; Wei Wang
Journal:  Methods       Date:  2019-03-07       Impact factor: 3.608

2.  Cardioinformatics: the nexus of bioinformatics and precision cardiology.

Authors:  Bohdan B Khomtchouk; Diem-Trang Tran; Kasra A Vand; Matthew Might; Or Gozani; Themistocles L Assimes
Journal:  Brief Bioinform       Date:  2020-12-01       Impact factor: 11.622

3.  Integrative OMICS Data-Driven Procedure Using a Derivatized Meta-Analysis Approach.

Authors:  Karla Cervantes-Gracia; Richard Chahwan; Holger Husi
Journal:  Front Genet       Date:  2022-02-04       Impact factor: 4.599

4.  Integrative Analysis of Incongruous Cancer Genomics and Proteomics Datasets.

Authors:  Karla Cervantes-Gracia; Richard Chahwan; Holger Husi
Journal:  Methods Mol Biol       Date:  2021
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.